BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 3, 2025
Breaking News: 100 days of uncertainty
See today's BioWorld Science
Home
» Completion of target enrollment in part A of phase I/II study of MRx-4DP0004 in asthma
To read the full story,
subscribe
or
sign in
.
Completion of target enrollment in part A of phase I/II study of MRx-4DP0004 in asthma
June 7, 2021
BioWorld Science
Respiratory
